https://www.moffitt.org/providers/andrew-kuykendall/?customer_id=871-397-4022&gad_source=1&gclid=CjwKCAiAiaC-BhBEEiwAjY99qEUZOrJC6jGfHvQHbG0HK9hrFZh-sbIoqC52RMIImwIWhh7MclrXhBoCrYEQAvD_BwE
Reducing Polycythemia Vera–Associated Thrombotic Risk Through Iron Regulation
In part 3 of a discussion with Andrew Kuykendall, MD, Moffitt Cancer Center, he talks of rusfertide’s ability to enable patients to live a more viable life and free them from being tethered to the need for regular phlebotomies.